BACKGROUND: The presynaptic norepinephrine transporter (NET) mediates synaptic clearance and recycling of norepinephrine. NET-deficient transgenic mice have elevated blood pressure (BP), heart rate, and catecholamine concentrations. However, the in-vivo effects of common NET variants on cardiovascular regulation at rest and during exercise are unknown. METHODS: We studied cardiovascular responses and plasma catecholamine concentrations at rest and during bicycle exercise at increasing workloads (25, 50, and 75 W) in 145 healthy participants. We used multiple linear regressions to analyze the effect of common, purportedly functional polymorphisms in NET (rs2242446 and rs28386840) on cardiovascular measures. RESULTS: 44 and 58.9% of participants carried at least one variant allele for NET T-182C and A-3081T, respectively. Systolic BP during exercise and systolic BP-area under the curve were higher in carriers of variant NET alleles (P=0.003 and 0.009 for T-182C and A-3081T, respectively) and NET haplotype -182C/-3081T compared with -182T/-3081A (all P<0.01). Diastolic BP during exercise was also higher at lower, but not at higher exercise stages in carriers of NET -182C (P<0.01) and -3081T variants (P<0.05). NET genotypes were not associated with catecholamine concentrations or heart rate. CONCLUSION: Common genetic NET variants (-182C and -3081T) are associated with greater BP response to exercise in humans.
BACKGROUND: The presynaptic norepinephrine transporter (NET) mediates synaptic clearance and recycling of norepinephrine. NET-deficient transgenic mice have elevated blood pressure (BP), heart rate, and catecholamine concentrations. However, the in-vivo effects of common NET variants on cardiovascular regulation at rest and during exercise are unknown. METHODS: We studied cardiovascular responses and plasma catecholamine concentrations at rest and during bicycle exercise at increasing workloads (25, 50, and 75 W) in 145 healthy participants. We used multiple linear regressions to analyze the effect of common, purportedly functional polymorphisms in NET (rs2242446 and rs28386840) on cardiovascular measures. RESULTS: 44 and 58.9% of participants carried at least one variant allele for NETT-182C and A-3081T, respectively. Systolic BP during exercise and systolic BP-area under the curve were higher in carriers of variant NET alleles (P=0.003 and 0.009 for T-182C and A-3081T, respectively) and NET haplotype -182C/-3081T compared with -182T/-3081A (all P<0.01). Diastolic BP during exercise was also higher at lower, but not at higher exercise stages in carriers of NET -182C (P<0.01) and -3081T variants (P<0.05). NET genotypes were not associated with catecholamine concentrations or heart rate. CONCLUSION: Common genetic NET variants (-182C and -3081T) are associated with greater BP response to exercise in humans.
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: Christoph Schroeder; Jens Tank; Michael Boschmann; Andre Diedrich; Arya M Sharma; Italo Biaggioni; Friedrich C Luft; Jens Jordan Journal: Circulation Date: 2002-01-22 Impact factor: 29.690
Authors: J R Shannon; N L Flattem; J Jordan; G Jacob; B K Black; I Biaggioni; R D Blakely; D Robertson Journal: N Engl J Med Date: 2000-02-24 Impact factor: 91.245
Authors: G G Sofowora; V Dishy; M Muszkat; H G Xie; R B Kim; P A Harris; H C Prasad; D W Byrne; U B Nair; A J J Wood; C M Stein Journal: Clin Pharmacol Ther Date: 2003-04 Impact factor: 6.875
Authors: Jeanne M McCaffery; Michael F Pogue-Geile; Robert E Ferrell; Nancy Petro; Stephen B Manuck Journal: J Hypertens Date: 2002-06 Impact factor: 4.844
Authors: T Rice; T Rankinen; M A Province; Y C Chagnon; L Pérusse; I B Borecki; C Bouchard; D C Rao Journal: Circulation Date: 2000-10-17 Impact factor: 29.690
Authors: Utkarsh Kohli; Mordechai Muszkat; Gbenga G Sofowora; Paul A Harris; Eitan A Friedman; William D Dupont; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik Journal: Eur J Pain Date: 2009-05-06 Impact factor: 3.931
Authors: Utkarsh Kohli; André Diedrich; Prince J Kannankeril; Mordechai Muszkat; Gbenga G Sofowora; Maureen K Hahn; Brett A English; Randy D Blakely; C Michael Stein; Daniel Kurnik Journal: Physiol Genomics Date: 2015-06-09 Impact factor: 3.107
Authors: Laxmi V Ghimire; Utkarsh Kohli; Chun Li; Gbenga G Sofowora; Mordechai Muszkat; Eitan A Friedman; Joseph F Solus; Alastair J J Wood; C Michael Stein; Daniel Kurnik Journal: Pharmacogenet Genomics Date: 2012-04 Impact factor: 2.089
Authors: H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn Journal: Genes Brain Behav Date: 2013-10-09 Impact factor: 3.449
Authors: Thomas Liebe; Shijia Li; Anton Lord; Lejla Colic; Anna Linda Krause; Anil Batra; Moritz A Kretzschmar; Catherine M Sweeney-Reed; Gusalija Behnisch; Björn H Schott; Martin Walter Journal: Int J Neuropsychopharmacol Date: 2017-11-01 Impact factor: 5.176
Authors: Thomas Liebe; Meng Li; Lejla Colic; Matthias H J Munk; Catherine M Sweeney-Reed; Marie Woelfer; Moritz A Kretzschmar; Johann Steiner; Felicia von Düring; Gusalija Behnisch; Björn H Schott; Martin Walter Journal: Neuroimage Clin Date: 2018-09-04 Impact factor: 4.881